
0.3494 Delayed Data As of May 27 | ![]() Today’s Change | 0.34 Today|||52-Week Range 21.30 | -93.80% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 30.00, with a high estimate of 45.00 and a low estimate of 2.00. The median estimate represents a +8,486.15% increase from the last price of 0.35.
The current consensus among 3 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.